Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

Potential pancoronavirus fusion inhibitors that are effective against SARS-CoV-2 variants

A new study successfully identifies a series of inhibitors that possesses pancoronavirus activity against SARS-CoV, SARS-CoV-2, and MERS-CoV.

7 Sep 2021

Highly neutralizing human convalescent plasma reduces lung inflammation in SARS-CoV-2-infected macaques

A new study reignites the debate regarding the therapeutic utility of convalescent plasma in treating others with the COVID-19.

7 Sep 2021

Optical biosensors enable fast, accurate, point-of-care COVID-19 diagnosis

Without the prospect of herd immunity on the immediate horizon, speedy detection for COVID-19 remains imperative for helping to curb the pandemic. Point-of-care testing that can provide immediate results is an urgent need.

7 Sep 2021

Understanding how pathogens evolve novel virulence activities

Understanding how pathogens evolve is a fundamental component of learning how to protect ourselves and our world from pests and diseases.

7 Sep 2021

New £36 billion investment to bring health and social care system closer to sustainable footing

The Prime Minister today set out responsible, fair, and necessary plans to tackle the Covid backlogs, reform adult social care, and bring the health and social care system closer together on a long term, sustainable footing.

7 Sep 2021

Effects of non-pharmaceutical interventions and mutations on COVID-19 resurgence

A recent study addresses the effects of controlling non-pharmaceutical interventions to develop a deeper understanding of their influence on the resurgence of COVID-19.

7 Sep 2021

Fact-checking is an effective tool to combat misinformation, study shows

Fact-checking reduces belief in misinformation and leaves a more enduring mental imprint than false claims, according to a new study published today in the Proceedings of the National Academy of Sciences.

7 Sep 2021

Severe COVID-19 is associated with expansion of immature myeloid cells and inflammation

A team of scientists in Ireland recently identified certain immune markers that can predict the progression of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection to severe coronavirus disease 2019 (COVID-19). Early detection of these predictive markers can facilitate therapeutic decision-making prior to peak severity.

7 Sep 2021

Combining Big Health’s digital therapeutic for insomnia and IAPT therapy improves mental health

Big Health, a digital therapeutics company dedicated to helping millions back to good mental health, and the Oxford Health NHS Foundation Trust today announced a joint study published in the Behavior Research and Therapy journal showing almost two-thirds of people seeking treatment for anxiety or depression and who had sleep difficulty saw their mental health improve substantially more by combining enrollment in Sleepio, Big Health’s digital therapeutic for insomnia, with NHS Improving Access to Psychological Therapies programme care, when compared to IAPT care alone.

7 Sep 2021

The pandemic almost killed Allie. Her community’s vaccination rate is 45%.

The Allie Henderson who stepped out of her mother's car to a driveway full of cheering friends and family holding "Welcome Home" signs was a wisp of her former self.

7 Sep 2021

High COVID-19 vaccine effectiveness in Israeli HCP

A study aimed to evaluate the VE against SARS-CoV-2 infection by carrying out a prospective cohort study that included healthcare personnel (HCP) in six hospitals in Israel.

7 Sep 2021

Delta and low vaccination rates projected to cause COVID-19 resurgence in United States

In a new medRxiv* preprint study, a team of researchers led by Cécile Viboud of the National Institute of Health analyzed different models predicting the course of the pandemic in the United States for the rest of 2021.

7 Sep 2021

New analysis provides timely information on disparities in vaccine confidence among US adults

A peer-reviewed analysis of US national survey data of 75,000 adults shows, from early January to late March, a near "18 percentage point" increase of adults who have either had the COVID-19 vaccine jab or are willing to do have it.

7 Sep 2021

COVID-19 infection does not appear to affect the lung function of young adults, finds study

COVID-19 infection does not appear to affect the lung function of young adults, according to new research presented at the 'virtual' European Respiratory Society International Congress today (Tuesday).

7 Sep 2021

Multiplexed electrochemical sensor platform enables simultaneous detection of SARS-CoV-2 RNA and host antibodies

Scientists from the UK and USA have developed an antifouling nanocomposite-coated multiplexed electrochemical sensor platform that can simultaneously detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA and virus-specific antibodies. The platform has shown 100% accuracy in detecting viral RNA and IgG-specific anti-SARS-CoV-2 antibodies. The study is currently available on the medRxiv* preprint server.

6 Sep 2021

Study reveals Pfizer/BioNTech and Oxford/AstraZeneca COVID-19 vaccine efficacy and immune response in clinically vulnerable individuals

The current study found that a strong S-antibody response occurs following complete vaccination with two different COVID-19 vaccines.

6 Sep 2021

Pandemic News and Research

Further Reading

Potential pancoronavirus fusion inhibitors that are effective against SARS-CoV-2 variants

Highly neutralizing human convalescent plasma reduces lung inflammation in SARS-CoV-2-infected macaques

Optical biosensors enable fast, accurate, point-of-care COVID-19 diagnosis

Understanding how pathogens evolve novel virulence activities

New £36 billion investment to bring health and social care system closer to sustainable footing

Effects of non-pharmaceutical interventions and mutations on COVID-19 resurgence

Fact-checking is an effective tool to combat misinformation, study shows

Severe COVID-19 is associated with expansion of immature myeloid cells and inflammation

Combining Big Health’s digital therapeutic for insomnia and IAPT therapy improves mental health

The pandemic almost killed Allie. Her community’s vaccination rate is 45%.

High COVID-19 vaccine effectiveness in Israeli HCP

Delta and low vaccination rates projected to cause COVID-19 resurgence in United States

New analysis provides timely information on disparities in vaccine confidence among US adults

COVID-19 infection does not appear to affect the lung function of young adults, finds study

Multiplexed electrochemical sensor platform enables simultaneous detection of SARS-CoV-2 RNA and host antibodies

Study reveals Pfizer/BioNTech and Oxford/AstraZeneca COVID-19 vaccine efficacy and immune response in clinically vulnerable individuals

NHS to receive an extra £5.4 billion over next six months to support COVID-19 response

Study finds an increase in depression symptoms among UK adults aged 50-plus during the pandemic

Mystery deaths of children blamed on insanitary conditions and poor resources in India

New Health Declaration published with commitments from all G20 countries

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News